These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 37611534)
21. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors. Lamie PF; Philoppes JN; Rárová L Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411 [TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents. Li Z; Wang ZC; Li X; Abbas M; Wu SY; Ren SZ; Liu QX; Liu Y; Chen PW; Duan YT; Lv PC; Zhu HL Eur J Med Chem; 2019 May; 169():168-184. PubMed ID: 30877972 [TBL] [Abstract][Full Text] [Related]
24. Further insight into the dual COX-2 and 15-LOX anti-inflammatory activity of 1,3,4-thiadiazole-thiazolidinone hybrids: The contribution of the substituents at 5th positions is size dependent. Omar YM; Abdel-Moty SG; Abdu-Allah HHM Bioorg Chem; 2020 Apr; 97():103657. PubMed ID: 32086052 [TBL] [Abstract][Full Text] [Related]
25. Synthesis, in vivo anti-inflammatory, COX-1/COX-2 and 5-LOX inhibitory activities of new 2,3,4-trisubstituted thiophene derivatives. Qandeel NA; El-Damasy AK; Sharawy MH; Bayomi SM; El-Gohary NS Bioorg Chem; 2020 Sep; 102():103890. PubMed ID: 32801081 [TBL] [Abstract][Full Text] [Related]
27. Benzodioxole-Pyrazole Hybrids as Anti-Inflammatory and Analgesic Agents with COX-1,2/5-LOX Inhibition and Antioxidant Potential. Abd El Razik HA; Badr MH; Atta AH; Mouneir SM; Abu-Serie MM Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28418202 [TBL] [Abstract][Full Text] [Related]
28. Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS. Xie L; Lee DY; Shang Y; Cao X; Wang S; Liao J; Zhang T; Dai R Phytomedicine; 2020 Oct; 77():153284. PubMed ID: 32707371 [TBL] [Abstract][Full Text] [Related]
29. Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study. Lamie PF; Ali WAM; Bazgier V; Rárová L Eur J Med Chem; 2016 Nov; 123():803-813. PubMed ID: 27541263 [TBL] [Abstract][Full Text] [Related]
30. Benzimidazole scaffold based hybrid molecules for various inflammatory targets: Synthesis and evaluation. Kaur G; Silakari O Bioorg Chem; 2018 Oct; 80():24-35. PubMed ID: 29864685 [TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenase-2 and 15-lipoxygenase inhibition, synthesis, anti-inflammatory activity and ulcer liability of new celecoxib analogues: Determination of region-specific pyrazole ring formation by NOESY. Abdelall EKA; Lamie PF; Ali WAM Bioorg Med Chem Lett; 2016 Jun; 26(12):2893-2899. PubMed ID: 27158139 [TBL] [Abstract][Full Text] [Related]
32. Discovery of potential anti-inflammatory drugs: diaryl-1,2,4-triazoles bearing N-hydroxyurea moiety as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase. Jiang B; Huang X; Yao H; Jiang J; Wu X; Jiang S; Wang Q; Lu T; Xu J Org Biomol Chem; 2014 Apr; 12(13):2114-27. PubMed ID: 24562695 [TBL] [Abstract][Full Text] [Related]
33. Identification and development of thiazole leads as COX-2/5-LOX inhibitors through in-vitro and in-vivo biological evaluation for anti-inflammatory activity. Jacob P J; Manju SL Bioorg Chem; 2020 Jul; 100():103882. PubMed ID: 32361295 [TBL] [Abstract][Full Text] [Related]
34. Towards safer anti-inflammatory therapy: synthesis of new thymol-pyrazole hybrids as dual COX-2/5-LOX inhibitors. El-Miligy MMM; Al-Kubeisi AK; Bekhit MG; El-Zemity SR; Nassra RA; Hazzaa AA J Enzyme Inhib Med Chem; 2023 Dec; 38(1):294-308. PubMed ID: 36408833 [TBL] [Abstract][Full Text] [Related]
36. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study. El-Miligy MMM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SAM Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993 [TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and mechanistic study of novel diarylpyrazole derivatives as anti-inflammatory agents with reduced cardiovascular side effects. Amin NH; Hamed MIA; Abdel-Fattah MM; Abusabaa AHA; El-Saadi MT Bioorg Chem; 2021 Nov; 116():105394. PubMed ID: 34619468 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of anti-inflammatory and immunomodulatory effects of Premna integrifolia extracts and assay-guided isolation of a COX-2/5-LOX dual inhibitor. Azad R; Babu NK; Gupta AD; Reddanna P Fitoterapia; 2018 Nov; 131():189-199. PubMed ID: 30339925 [TBL] [Abstract][Full Text] [Related]
39. Click chemistry synthesis, biological evaluation and docking study of some novel 2'-hydroxychalcone-triazole hybrids as potent anti-inflammatory agents. Boshra AN; Abdu-Allah HHM; Mohammed AF; Hayallah AM Bioorg Chem; 2020 Jan; 95():103505. PubMed ID: 31901755 [TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. Reddy MV; Billa VK; Pallela VR; Mallireddigari MR; Boominathan R; Gabriel JL; Reddy EP Bioorg Med Chem; 2008 Apr; 16(7):3907-16. PubMed ID: 18272371 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]